Sexuality for people with schizophrenia is still an area under research. Healthcare experts are aiming to understand psychotic disorders in relation to sexuality alongside a greater understanding ...

Interestingly, the first English language report on the use of antipsychotic agents in schizophrenia also showed that these drugs have efficacy in the treatment of acute mania, which clinicians ...

The investigational combination xanomeline-trospium (KarXT) was effective and well tolerated in individuals with schizophrenia who were experiencing acute psychosis, according to the randomized ...

During acute episodes, patients may experience psychotic ... The driver, a man in his 50s, was later confirmed to have ...

(2024 Dec 11). The impact of xanomeline and trospium chloride on cognitive impairment in acute schizophrenia: replication in pooled data from two phase 3 trials. Am J Psychiatry. doi: 10.1176/appi.ajp ...

for the treatments of acute bipolar I disorder and schizophrenia. The NDA is supported by several clinical studies assessing the efficacy and safety of Bysanti™. Vanda Logo (PRNewsfoto/Vanda Pha ...

for the treatments of acute bipolar I disorder and schizophrenia. The NDA is supported by several clinical studies assessing the efficacy and safety of Bysanti. Bysanti is a new chemical entity ...

Enrollment exceeds 60% of required number of patients in SERENITY At-Home pivotal Phase 3 safety trial evaluating 200 patients for acute ...

Vanda Pharmaceuticals (VNDA) announced that a New Drug Application was submitted to the U.S. FDA requesting marketing approval of Bysanti for ...